Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 12603

  • Filters activated: Field: Title/Abstract. Clear all
1.

Mulberry leaf active components alleviate type 2 diabetes and its liver and kidney injury in db/db mice through insulin receptor and TGF-β/Smads signaling pathway.

Zhang L, Su S, Zhu Y, Guo J, Guo S, Qian D, Ouyang Z, Duan JA.

Biomed Pharmacother. 2019 Feb 16;112:108675. doi: 10.1016/j.biopha.2019.108675. [Epub ahead of print]

PMID:
30780108
2.

MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.

Zhang SZ, Qiu XJ, Dong SS, Zhou LN, Zhu Y, Wang MD, Jin LW.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1248-1256. doi: 10.26355/eurrev_201902_17018.

PMID:
30779094
3.

Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy.

Ahmed HH, Taha FM, Omar HS, Elwi HM, Abdelnasser M.

Mol Cell Biochem. 2019 Feb 18. doi: 10.1007/s11010-019-03506-x. [Epub ahead of print]

PMID:
30778838
4.

Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.

Manski-Nankervis JA, Thuraisingam S, Sluggett JK, Kilov G, Furler J, O'Neal D, Jenkins A.

BMC Fam Pract. 2019 Feb 18;20(1):29. doi: 10.1186/s12875-019-0915-x.

PMID:
30777033
5.

Screening Coronary Angiography in Patients with Long-Standing Diabetes Mellitus undergoing Kidney Transplant Evaluation.

Puttarajappa CM, Tevar AD, Hariharan S, Silver SJ, Soman P, Hendrick S, Mour G, Wu CM.

Clin Transplant. 2019 Feb 18:e13501. doi: 10.1111/ctr.13501. [Epub ahead of print]

PMID:
30776157
6.

Racial/Ethnic Trends in Prevalence of Diabetic Kidney Disease in the United States.

Dias JP, Shardell M, Golden SH, Ahima RS, Crews DC.

Kidney Int Rep. 2018 Oct 29;4(2):334-337. doi: 10.1016/j.ekir.2018.10.018. eCollection 2019 Feb. No abstract available.

7.

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?

Perco P, Pena M, Heerspink HJL, Mayer G; BEAt-DKD Consortium.

Kidney Int Rep. 2018 Dec 18;4(2):212-221. doi: 10.1016/j.ekir.2018.12.001. eCollection 2019 Feb. Review.

8.

Erratum Regarding "Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial" (Am J Kidney Dis. 2018;71[1]:65-74).

[No authors listed]

Am J Kidney Dis. 2019 Feb 14. pii: S0272-6386(19)30093-9. doi: 10.1053/j.ajkd.2019.02.001. [Epub ahead of print] No abstract available.

PMID:
30773238
9.

Prognostic Utility of Oxygen-Sensitive Cardiac Magnetic Resonance Imaging in Diabetic and Nondiabetic Chronic Kidney Disease Patients With No Known Coronary Artery Disease.

Shah R, Parnham S, Liang Z, Perry R, Bradbrook C, Smith E, Faull R, Woodman RJ, Nucifora G, Gleadle JM, Selvanayagam JB.

JACC Cardiovasc Imaging. 2019 Feb 11. pii: S1936-878X(19)30047-6. doi: 10.1016/j.jcmg.2018.12.014. [Epub ahead of print] No abstract available.

PMID:
30772234
10.

Diabetes Management in Older Adults With Chronic Kidney Disease.

Clemens KK, O'Regan N, Rhee JJ.

Curr Diab Rep. 2019 Feb 15;19(3):11. doi: 10.1007/s11892-019-1128-3. Review.

PMID:
30771017
11.

Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling.

Kim D, Li HY, Lee JH, Oh YS, Jun HS.

Exp Mol Med. 2019 Feb 15;51(2):18. doi: 10.1038/s12276-019-0217-3.

PMID:
30770784
12.

IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review.

Tonacci A, Quattrocchi P, Gangemi S.

Medicina (Kaunas). 2019 Feb 14;55(2). pii: E50. doi: 10.3390/medicina55020050. Review.

13.

Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.

Malek V, Sharma N, Sankrityayan H, Gaikwad AB.

Life Sci. 2019 Feb 12. pii: S0024-3205(19)30117-1. doi: 10.1016/j.lfs.2019.02.027. [Epub ahead of print]

PMID:
30769114
14.

The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes.

Woo V, Connelly K, Lin P, McFarlane P.

Curr Med Res Opin. 2019 Feb 15:1-13. doi: 10.1080/03007995.2019.1576479. [Epub ahead of print]

PMID:
30767677
15.

Impact on renal resistive index of diabetes in renal transplant donors and recipients: A retrospective analysis of 1827 kidney transplant recipients.

de Freminville JB, Vernier LM, Roumy J, Patat F, Gatault P, Sautenet B, Bailly E, Chevallier E, Barbet C, Longuet H, Merieau E, Baron C, Buchler M, Halimi JM.

J Clin Hypertens (Greenwich). 2019 Feb 14. doi: 10.1111/jch.13492. [Epub ahead of print]

16.

MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.

Zeng W, Qi W, Mu J, Wei Y, Yang LL, Zhang Q, Wu Q, Tang JY, Feng B.

Sci Rep. 2019 Feb 14;9(1):2049. doi: 10.1038/s41598-018-38425-2.

17.

Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study.

Coemans M, Van Loon E, Lerut E, Gillard P, Sprangers B, Senev A, Emonds MP, Van Keer J, Callemeyn J, Daniëls L, Sichien J, Verbeke G, Kuypers D, Mathieu C, Naesens M.

Diabetes Care. 2019 Feb 14. pii: dc181936. doi: 10.2337/dc18-1936. [Epub ahead of print]

PMID:
30765434
18.

Development of Charcot Neuroarthropathy in Diabetic Patients who Received Kidney or Kidney-Pancreas Transplants.

Anthony ML, Cravey KS, Atway SA.

J Foot Ankle Surg. 2019 Feb 11. pii: S1067-2516(18)30426-5. doi: 10.1053/j.jfas.2018.09.022. [Epub ahead of print]

PMID:
30765253
19.

Corrigendum to "Schisandrin B alleviates diabetic nephropathy through suppressing excessive inflammation and oxidative stress" Biochem. Biophys. Res. Commun. 508 (2019): 243-249.

Mou Z, Feng Z, Xu Z, Zhuang F, Zheng X, Li X, Qian J, Liang G.

Biochem Biophys Res Commun. 2019 Feb 12. pii: S0006-291X(19)30214-1. doi: 10.1016/j.bbrc.2019.02.027. [Epub ahead of print] No abstract available.

PMID:
30765223
20.

Association between PNPLA3rs738409, polymorphism, decreased kidney function in postmenopausal type 2, diabetic women with or without non-alcoholic fatty liver disease.

Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza G, Valenti L, Byrne CD, Maffeis C, Bonora E, Targher G.

Diabetes Metab. 2019 Feb 11. pii: S1262-3636(19)30026-6. doi: 10.1016/j.diabet.2019.01.011. [Epub ahead of print]

PMID:
30763699

Supplemental Content

Loading ...
Support Center